We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HST icon
701
Host Hotels & Resorts
HST
$16B
$319K 0.05%
+21,800
New +$282K
MTRX icon
702
Matrix Service
MTRX
$335M
$318K 0.05%
28,895
+9,300
+47% +$85.7K
CLB icon
703
Core Laboratories
CLB
$521M
$317K 0.05%
11,950
-6,024
-34% -$123K
IYW icon
704
iShares US Technology ETF
IYW
$25.5B
$316K 0.05%
+3,716
New +$297K
GNCA
705
DELISTED
Genocea Biosciences, Inc.
GNCA
$316K 0.05%
+130,745
New +$298K
UPLD icon
706
Upland Software
UPLD
$15.4M
$315K 0.05%
+686
New +$302K
AMBA icon
707
Ambarella
AMBA
$3.81B
$313K 0.05%
+3,405
New +$238K
L icon
708
Loews
L
$23.6B
$313K 0.05%
+6,950
New +$279K
ING icon
709
ING
ING
$102B
$312K 0.05%
+33,078
New +$284K
AIRG icon
710
Airgain
AIRG
$72.4M
$311K 0.05%
17,479
+3,059
+21% +$42.6K
P
711
Everpure Inc
P
$29.9B
$311K 0.05%
+13,733
New +$263K
GPI icon
712
Group 1 Automotive
GPI
$3.18B
$310K 0.05%
+2,361
New +$284K
DXPE icon
713
DXP Enterprises
DXPE
$2.98B
$309K 0.05%
13,915
-16,057
-54% -$324K
RILY icon
714
BRC Group Holdings
RILY
$289M
$309K 0.05%
6,981
-2,689
-28% -$86.6K
SMBK icon
715
SmartFinancial
SMBK
$888M
$308K 0.05%
16,968
+6,596
+64% +$109K
CWCO icon
716
Consolidated Water Co
CWCO
$488M
$307K 0.05%
25,442
+8,423
+49% +$93.7K
FBNC icon
717
First Bancorp
FBNC
$2.68B
$306K 0.05%
9,045
-9,794
-52% -$284K
LBTYA icon
718
Liberty Global Class A
LBTYA
$3.6B
$306K 0.05%
12,614
-7,214
-36% -$161K
NPO icon
719
Enpro
NPO
$7.05B
$306K 0.05%
+4,053
New +$272K
CIT
720
DELISTED
CIT Group Inc.
CIT
$306K 0.05%
+8,532
New +$269K
LII icon
721
Lennox International
LII
$15.2B
$305K 0.05%
+1,115
New +$317K
ACH
722
Accendra Health
ACH
$214M
$305K 0.05%
+11,284
New +$290K
MCBC
723
DELISTED
Macatawa Bank Corp
MCBC
$305K 0.05%
36,391
+23,180
+175% +$179K
FOXA icon
724
Fox Class A
FOXA
$26.9B
$304K 0.05%
+10,438
New +$292K
PFE icon
725
Pfizer
PFE
$153B
$304K 0.05%
+8,257
New +$303K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.